| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $244K | — | +1559.4% |
| Cost of Revenue | $48 | — | +0.0% |
| Gross Profit | $244K | — | +1564.9% |
| R&D Expense | $287K | — | -57.4% |
| SG&A Expense | $4.5M | — | +89.4% |
| Operating Income | $8.7M | — | +388.1% |
| Net Income | $8.8M | — | +353.8% |
| EPS (Basic) | $0.30 | — | +118.9% |
| EPS (Diluted) | $0.26 | — | +116.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.4M | +14.5% | +87.6% |
| Current Assets | $8.8M | +21.5% | +70.7% |
| Total Assets | $70.1M | +35.4% | +1070.9% |
| Current Liabilities | $4.5M | +65.6% | -70.4% |
| Total Liabilities | $11.6M | +8.1% | -26.3% |
| Stockholders' Equity | $58.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.2M | — | +5.5% |
| Investing Cash Flow | -$1.5M | — | — |
| Financing Cash Flow | $6.6M | — | +5.6% |
| +702.2% |